Panasonic Executive Partner

Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board

Retrieved on: 
Tuesday, April 2, 2024
Research, Genetics, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Science, Oncology, Principal, Harvard Medical School, Education, DSM-IV codes, Associate, Nanoparticle, Patient, Biomedicine, RNA, Flagship Pioneering, Columbia University, AI, Faculty, Personalized medicine, Panasonic Executive Partner, Infection, Hospital, Division, Therapy, Medical director, Genomics, Nursing

Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Wendy Chung, M.D., Ph.D., has joined Sail’s Board of Directors.

Key Points: 
  • Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Wendy Chung, M.D., Ph.D., has joined Sail’s Board of Directors.
  • Dr. Chung currently serves as Chief of the Department of Pediatrics of Boston Children’s Hospital, sits on the faculty at Harvard Medical School, and is President of the Children’s Hospital Pediatric Associates.
  • Dr. Chung brings to Sail’s board more than 20 years of experience as a clinical and molecular geneticist, as well as biotech operational experience.
  • “I’m thrilled to contribute to Sail’s mission to create breakthroughs for patients with new types of RNA therapeutics and to join Sail’s distinguished Board of Directors,” said Dr. Chung.

New Representatives & Officers Added to Association of Executive Search & Leadership Consultants' Americas, EMEA & APAC Councils

Retrieved on: 
Thursday, April 4, 2024
Olive, Financial services, Health care, Panasonic Executive Partner, Council, Russell Reynolds, Marketing, Gulf Cooperation Council, Partner, Leisure, Partnership, Business, Education, Russell Reynolds Associates, Emerging market, Organization, Communication, Associate, Heidrick & Struggles, Insurance, Consultant, Chair, Final good, Entrepreneurship, Partner (business rank), GTPase, Local government, MENA, Completeness, Region, Multimedia, Government, Management

NEW YORK, April 4, 2024 /PRNewswire-PRWeb/ -- The Association of Executive Search and Leadership Consultants (AESC), representing the top executive search and leadership consulting firms worldwide, today announces 2024 officers and representatives appointed to AESC's Americas Council, EMEA Council and APAC Council. Each Council consists of elected officers and representatives from AESC Member executive search and leadership advisory firms from across their respective region.

Key Points: 
  • NEW YORK, April 4, 2024 /PRNewswire-PRWeb/ -- The Association of Executive Search and Leadership Consultants (AESC), representing the top executive search and leadership consulting firms worldwide, today announces 2024 officers and representatives appointed to AESC's Americas Council , EMEA Council and APAC Council .
  • Each Council consists of elected officers and representatives from AESC Member executive search and leadership advisory firms from across their respective region.
  • She currently specializes in executive search and leadership consulting for senior management in the local and Latin American markets.
  • Thorsten Amend-Schnaar , Frankfurt-based Executive Partner at Höchsmann & Company GmbH & Co. KG, has provided executive search and leadership consulting since 2013.

Mill Point Capital Completes Sale of Prime Pensions

Retrieved on: 
Monday, February 26, 2024
Small Business, Accounting, Professional Services, Finance, Growth, Proposition, TPA, Sale, Panasonic Executive Partner, Corporate services, Pension, Partnership, Financial adviser

Mill Point Capital LLC (“Mill Point Capital”), a private equity firm focused on control investments in middle-market companies in North America across the Business Services, Industrials and IT Services sectors, announced today a sale of Prime Pensions, LLC (“Prime Pensions” or the “Company”), a leading independent third-party administrator (“TPA”) and provider of retirement plan compliance and administration services.

Key Points: 
  • Mill Point Capital LLC (“Mill Point Capital”), a private equity firm focused on control investments in middle-market companies in North America across the Business Services, Industrials and IT Services sectors, announced today a sale of Prime Pensions, LLC (“Prime Pensions” or the “Company”), a leading independent third-party administrator (“TPA”) and provider of retirement plan compliance and administration services.
  • “We are incredibly proud of our successful partnership with Scott Feit, Founder and CEO of Prime Pensions, as well as the entire Prime Pensions team over the past few years.
  • Their dedication to Prime Pensions is evident and we are thrilled to watch the Company’s continued future success,” commented Jenni Main, Executive Partner of Mill Point Capital.
  • Raymond James acted as the exclusive financial advisor to Mill Point Capital and Prime Pensions.

J.P. Morgan Life Sciences Private Capital Team Adds Healthcare Veteran and Past Seagen CEO David Epstein to Advisory Board

Retrieved on: 
Tuesday, February 27, 2024
Rubius, Odyssey, Senior, Inborn errors of metabolism, Investment, Drug development, Growth, Sale, IPO, University, Intuitive Surgical, Neurodegenerative disease, Analog Devices, National academy, J. P. Morgan, MIT, Genetic distance, American Philosophical Society, Business development, Journal, Therapy, Imatinib, SRL Diagnostics, MidOcean Partners, Distinction, Laboratory, Cornell University, Drug discovery, Weill Cornell Medicine, Provost, Panasonic Executive Partner, Abbott Laboratories, Flagship, Novartis, Medtronic, MACP, Harvard Medical School, Nilotinib, American Academy, Yale School of Medicine, JPMorgan Chase, AI, MD, Flagship Pioneering, Harvard University, MassMutual, Executive, Cancer, Management

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital today announced the addition of David Epstein to its Healthcare Advisory Board.

Key Points: 
  • NEW YORK, Feb. 27, 2024 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital today announced the addition of David Epstein to its Healthcare Advisory Board.
  • Mr. Epstein will now advise the J.P. Morgan Life Sciences Private Capital team.
  • The J.P. Morgan Life Sciences Private Capital team leverages JPMorgan Chase's scale, resources, data assets and healthcare expertise and sits within J.P. Morgan Private Capital, a venture and growth equity investment platform that is part of J.P. Morgan Asset Management.
  • The platform finances the continued growth of private companies and taps into significant pre-IPO value creation opportunities in the consumer and technology, and life sciences sectors.

The Association of Executive Search & Leadership Consultants Appoints 2024 Board & Council Leadership

Retrieved on: 
Wednesday, February 7, 2024
Heidrick & Struggles, CFO, Telecommunications, Associate, Spencer Stuart, Chair, Government, Marketing, Council, Partner, Panasonic Executive Partner, Stanton Chase, Health care, Russell Reynolds Associates, Management

NEW YORK, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Association of Executive Search and Leadership Consultants (AESC), representing the top executive search and leadership consulting firms worldwide, today announces 2024 Board and Council officers, in addition to the appointments of three new Directors to its Global Board.

Key Points: 
  • NEW YORK, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Association of Executive Search and Leadership Consultants (AESC), representing the top executive search and leadership consulting firms worldwide, today announces 2024 Board and Council officers, in addition to the appointments of three new Directors to its Global Board.
  • Our Board, our regional Councils and all AESC members ensure that we collaborate for the good of our profession – strengthening leadership together.
  • Julian Ha , Chair, Washington, DC-based Partner and Leader of the Government Affairs and Trade Association practices at Heidrick & Struggles, will now serve as AESC Global Chair.
  • AESC was founded in 1959 focused on ensuring that our profession – executive search and leadership consulting – maintains the highest commitment to quality and professional standards.

Valo Health Announces Changes to its Board of Directors and Leadership Team

Retrieved on: 
Tuesday, January 16, 2024
Artificial intelligence, Patient, Employment, Health, Flagship Pioneering, CFO, Bell, Panasonic Executive Partner, Executive, Drug discovery, Schade, Therapy, Management

BOSTON, Jan. 16, 2024 /PRNewswire/ -- Valo Health, Inc ("Valo"), a technology company focused on utilizing large scale data and artificial intelligence ("AI") driven computation to discover and develop therapeutics, today announced the appointment of Christian Schade as the newly-created role of Executive Chairman of the Board of Directors­ and Graeme Bell as interim CEO, effective immediately.

Key Points: 
  • Schade has served as a Board Director for Valo Health since September 2023, a role he took on after joining Flagship Pioneering as Growth Partner in January 2023.
  • D., who has served as CEO of Valo Health since its launch by Flagship Pioneering in 2019 and whose last day of employment is February 2.
  • "Chris and Graeme have made tremendous contributions to Valo during their tenure, and the Board of Directors is confident they are the right leaders for Valo's future," said Paul Biondi, Chairman of the Board of Directors, Valo Health, and Executive Partner, Flagship Pioneering.
  • "The tremendously talented team at Valo and the organization's deep commitment to our mission have inspired me since joining the company," added Bell.

DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING

Retrieved on: 
Tuesday, January 9, 2024
Farmer, Food, Flagship Pioneering, Investment, Agriculture, Panasonic Executive Partner, CPG, Carbon, Bank, AG, Soil, Tyson Foods, Growth, Management

CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Indigo Ag, an innovative leader and trusted partner in sustainable agriculture, today announced that Dean Banks will join Flagship Pioneering as CEO-Partner and CEO of Indigo Ag, effective February 1, 2024. Banks will also continue as an Indigo board member, a role he has held since July 2022. Indigo also announced the appointments of Nader Bekhouche (Investment Corporation of Dubai) and Noubar Afeyan (Flagship Pioneering) to its Board of Directors. As a follow up to the company's initial financing announcement in September 2023, Indigo also announced the final close of its financing round at an expanded raise of nearly $270 million.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Indigo Ag, an innovative leader and trusted partner in sustainable agriculture, today announced that Dean Banks will join Flagship Pioneering as CEO-Partner and CEO of Indigo Ag, effective February 1, 2024.
  • Banks will also continue as an Indigo board member, a role he has held since July 2022.
  • Indigo also announced the appointments of Nader Bekhouche (Investment Corporation of Dubai) and Noubar Afeyan (Flagship Pioneering) to its Board of Directors.
  • "I'm thrilled to take on the role of CEO of Indigo Ag.

Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board

Retrieved on: 
Thursday, January 4, 2024
Software, Research, General Health, Pharmaceutical, Data Management, Technology, Artificial Intelligence, Genetics, Health Technology, Science, Biotechnology, Health, RNA, Panasonic Executive Partner, Sale, CFO, Messenger, KKR, Acquisition, Medivation, Flagship Pioneering, MBA, Capsugel, Hospira, Biomedicine, Growth, Lucent, Management

Mr. D’Amelio brings to Sail’s board an accomplished record as a technology and pharmaceutical operations, finance and global supply executive.

Key Points: 
  • Mr. D’Amelio brings to Sail’s board an accomplished record as a technology and pharmaceutical operations, finance and global supply executive.
  • At Lucent, he played a critical role in its spinout from AT&T.
  • “I’m honored to be joining the Sail Biomedicines Board of Directors at a pivotal time for the company,” said Mr. D’Amelio.
  • “Sail’s vision and platform, which builds on over eight years of experimentation, represents an exciting opportunity to generate new medicines and forge innovative relationships with partners.

Grant Thornton LLP announces new Partners and Principals for 2024

Retrieved on: 
Tuesday, January 2, 2024
Partner, Principal, Panasonic Executive Partner, Accounting

TORONTO, Jan. 2, 2024 /CNW/ - Leading Canadian accounting and business advisory Firm, Grant Thornton LLP, is thrilled to introduce its new Partners and Principals.

Key Points: 
  • TORONTO, Jan. 2, 2024 /CNW/ - Leading Canadian accounting and business advisory Firm, Grant Thornton LLP, is thrilled to introduce its new Partners and Principals.
  • These exceptional leaders will continue to help us deliver on our purpose to help our clients, colleagues, and communities thrive.
  • "Congratulations to our new Partners and Principals for reaching this significant milestone on their career journey," says Kevin Ladner, Executive Partner and CEO, Grant Thornton LLP.
  • "Each of these leaders will play an important role in the future of our Firm and the value we provide to our clients, colleagues, and communities."

GDA Announces 2024 Partnership with the Texas Blockchain Council

Retrieved on: 
Tuesday, November 14, 2023
Partner, GDA, Council, Miner, Panasonic Executive Partner, Cryptocurrency

GDA expects to benefit from the Executive Partnership in a number of ways, including greater opportunities to connect with members of the Council such as other miners and startups, and the ability to participate in Texas Blockchain Council's initiatives and working groups.

Key Points: 
  • GDA expects to benefit from the Executive Partnership in a number of ways, including greater opportunities to connect with members of the Council such as other miners and startups, and the ability to participate in Texas Blockchain Council's initiatives and working groups.
  • "We believe that Texas is one of the most important hubs in the world for bitcoin mining.
  • So our decision to become Executive Partners was very natural given the amazing work that the Texas Blockchain Council is doing in the space" said Abdumalik Mirakhmedov, Executive President at GDA.
  • "The Texas Blockchain Council is thankful to have members like GDA who strive to be responsible actors on the grid, accountable corporate citizens, and reliable community partners" said Lee Bratcher, President and Founder of the Texas Blockchain Council, "we have seen firsthand how GDA works with the local communities in which their data centers operate and how those communities are benefiting not only from a financial and fiscal perspective, but also through community partnerships."